Oscotec Inc. (039200.KQ)
KRW 24450.0
(-2.4%)
KRW 24450.0
(-2.4%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -30.62 Billion KRW | -14.53% |
| 2022 | -28.51 Billion KRW | -1.8% |
| 2021 | -28.01 Billion KRW | -2420.02% |
| 2020 | -1.11 Billion KRW | 94.93% |
| 2019 | -21.92 Billion KRW | -454.92% |
| 2018 | 6.17 Billion KRW | 206.41% |
| 2017 | -5.8 Billion KRW | -233.75% |
| 2016 | -1.73 Billion KRW | -355.58% |
| 2015 | 680.59 Million KRW | 189.99% |
| 2014 | -756.27 Million KRW | 14.56% |
| 2013 | -885.16 Million KRW | -11.64% |
| 2012 | -792.84 Million KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -7.93 Billion KRW | 22.93% |
| 2024 Q2 | -7.32 Billion KRW | 15.6% |
| 2023 Q1 | -7.48 Billion KRW | -28.61% |
| 2023 Q3 | -8.01 Billion KRW | -16.59% |
| 2023 Q4 | -10.29 Billion KRW | -28.49% |
| 2023 FY | -32.65 Billion KRW | -14.53% |
| 2023 Q2 | -6.87 Billion KRW | 8.14% |
| 2022 Q4 | -5.81 Billion KRW | 22.09% |
| 2022 Q3 | -7.46 Billion KRW | -12.58% |
| 2022 Q1 | -8.64 Billion KRW | -87.42% |
| 2022 FY | -28.51 Billion KRW | -1.8% |
| 2022 Q2 | -6.63 Billion KRW | 23.27% |
| 2021 Q2 | -6.04 Billion KRW | 42.19% |
| 2021 Q4 | -4.61 Billion KRW | 34.13% |
| 2021 Q1 | -10.44 Billion KRW | -214.83% |
| 2021 FY | -28.01 Billion KRW | -2420.02% |
| 2021 Q3 | -7 Billion KRW | -15.9% |
| 2020 Q2 | 7.2 Billion KRW | 202.71% |
| 2020 Q1 | -7.01 Billion KRW | -10.48% |
| 2020 Q4 | 9.09 Billion KRW | 217.93% |
| 2020 FY | -1.11 Billion KRW | 94.93% |
| 2020 Q3 | -7.71 Billion KRW | -207.12% |
| 2019 Q2 | -6.85 Billion KRW | -50.54% |
| 2019 FY | -21.92 Billion KRW | -454.92% |
| 2019 Q4 | -6.34 Billion KRW | -52.57% |
| 2019 Q3 | -4.16 Billion KRW | 39.35% |
| 2019 Q1 | -4.55 Billion KRW | -135.87% |
| 2018 Q1 | -845.6 Million KRW | 59.2% |
| 2018 Q3 | -4.24 Billion KRW | -196.3% |
| 2018 FY | 6.17 Billion KRW | 206.41% |
| 2018 Q4 | 12.7 Billion KRW | 399.14% |
| 2018 Q2 | -1.43 Billion KRW | -69.48% |
| 2017 FY | -5.8 Billion KRW | -233.75% |
| 2017 Q3 | -1.41 Billion KRW | -20.23% |
| 2017 Q4 | -2.07 Billion KRW | -46.17% |
| 2017 Q2 | -1.17 Billion KRW | -3.81% |
| 2017 Q1 | -1.13 Billion KRW | 75.29% |
| 2016 Q3 | -617.68 Million KRW | 28.24% |
| 2016 Q1 | -579.18 Million KRW | -321.39% |
| 2016 Q2 | -860.8 Million KRW | -48.62% |
| 2016 FY | -1.73 Billion KRW | -355.58% |
| 2016 Q4 | -4.59 Billion KRW | -644.31% |
| 2015 Q3 | 1.2 Billion KRW | 310.8% |
| 2015 Q4 | 261.61 Million KRW | -78.2% |
| 2015 Q2 | -569.34 Million KRW | -168.73% |
| 2015 Q1 | -211.86 Million KRW | 67.61% |
| 2015 FY | 680.59 Million KRW | 189.99% |
| 2014 Q1 | -98.31 Million KRW | 95.77% |
| 2014 FY | -756.27 Million KRW | 14.56% |
| 2014 Q4 | -654.14 Million KRW | -4871.98% |
| 2014 Q3 | 13.7 Million KRW | 178.24% |
| 2014 Q2 | -17.52 Million KRW | 82.18% |
| 2013 Q2 | 270.6 Million KRW | -73.56% |
| 2013 Q3 | 147.36 Million KRW | -45.54% |
| 2013 Q1 | 1.02 Billion KRW | 149.63% |
| 2013 Q4 | -2.32 Billion KRW | -1678.79% |
| 2013 FY | -885.16 Million KRW | -11.64% |
| 2012 Q4 | -2.06 Billion KRW | -380.64% |
| 2012 FY | -792.84 Million KRW | 0.0% |
| 2012 Q3 | 734.75 Million KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BCWORLD PHARM. Co., Ltd. | 6.36 Billion KRW | 581.199% |